145 related articles for article (PubMed ID: 7514063)
1. Distribution of C3-step regulatory proteins of the complement system, CD35 (CR1), CD46 (MCP), and CD55 (DAF), in hematological malignancies.
Seya T; Matsumoto M; Hara T; Hatanaka M; Masaoka T; Akedo H
Leuk Lymphoma; 1994 Feb; 12(5-6):395-400. PubMed ID: 7514063
[TBL] [Abstract][Full Text] [Related]
2. Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies.
Hara T; Kojima A; Fukuda H; Masaoka T; Fukumori Y; Matsumoto M; Seya T
Br J Haematol; 1992 Oct; 82(2):368-73. PubMed ID: 1384649
[TBL] [Abstract][Full Text] [Related]
3. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
Seya T; Hara T; Matsumoto M; Akedo H
J Immunol; 1990 Jul; 145(1):238-45. PubMed ID: 1694203
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of complement decay-accelerating factor (DAF, CD55) in non-Hodgkin's lymphoma.
Fukuda H; Seya T; Hara T; Matsumoto M; Kinoshita T; Masaoka T
Immunol Lett; 1991 Aug; 29(3):205-9. PubMed ID: 1722775
[TBL] [Abstract][Full Text] [Related]
6. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.
Fishelson Z; Donin N; Zell S; Schultz S; Kirschfink M
Mol Immunol; 2003 Sep; 40(2-4):109-23. PubMed ID: 12914817
[TBL] [Abstract][Full Text] [Related]
7. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.
Nuutila J; Jalava-Karvinen P; Hohenthal U; Kotilainen P; Pelliniemi TT; Nikoskelainen J; Lilius EM
Hum Immunol; 2013 May; 74(5):522-30. PubMed ID: 23376460
[TBL] [Abstract][Full Text] [Related]
8. [Cell-associated complement regulatory proteins and their relation to disease processes].
Seya T
Rinsho Byori; 1991 Dec; 39(12):1317-24. PubMed ID: 1723433
[TBL] [Abstract][Full Text] [Related]
9. A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro.
Christiansen D; Milland J; Thorley BR; McKenzie IF; Loveland BE
Eur J Immunol; 1996 Mar; 26(3):578-85. PubMed ID: 8605924
[TBL] [Abstract][Full Text] [Related]
10. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury.
D'Cruz OJ; Haas GG
Fertil Steril; 1993 Apr; 59(4):876-84. PubMed ID: 7681414
[TBL] [Abstract][Full Text] [Related]
11. Altered Expression of Complement Regulatory Proteins CD35, CD46, CD55, and CD59 on Leukocyte Subsets in Individuals Suffering From Coronary Artery Disease.
Mishra N; Mohata M; Narang R; Lakshmy R; Hazarika A; Pandey RM; Das N; Luthra K
Front Immunol; 2019; 10():2072. PubMed ID: 31555286
[TBL] [Abstract][Full Text] [Related]
12. X-irradiation does not affect the levels of complement regulatory proteins, CD35 (CR1), CD55 (DAF) and CD59 on concentrated red cells.
Fukumori Y; Seya T; Ohnoki S; Shibata H; Yamaguchi H
Vox Sang; 1996; 71(4):243-4. PubMed ID: 8958650
[No Abstract] [Full Text] [Related]
13. Expression of complement regulatory proteins on human eggs and preimplantation embryos.
Fenichel P; Donzeau M; Cervoni F; Menezo Y; Hsi BL
Am J Reprod Immunol; 1995 Feb; 33(2):155-64. PubMed ID: 7544131
[TBL] [Abstract][Full Text] [Related]
14. Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue.
Murray KP; Mathure S; Kaul R; Khan S; Carson LF; Twiggs LB; Martens MG; Kaul A
Gynecol Oncol; 2000 Feb; 76(2):176-82. PubMed ID: 10637067
[TBL] [Abstract][Full Text] [Related]
15. Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1.
Seya T; Okada M; Hara T; Matsumoto M; Miyagawa S; Oshimura M
Immunology; 1991 Dec; 74(4):719-24. PubMed ID: 1723716
[TBL] [Abstract][Full Text] [Related]
16. Distribution of complement regulators (CD46, CD55 and CD59) in skin appendages, and in benign and malignant skin neoplasms.
Sayama K; Shiraishi S; Miki Y
Br J Dermatol; 1992 Jul; 127(1):1-4. PubMed ID: 1379063
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line.
Bjørge L; Jensen TS; Matre R
Cancer Immunol Immunother; 1996 Mar; 42(3):185-92. PubMed ID: 8640847
[TBL] [Abstract][Full Text] [Related]
18. Levels of complement regulatory molecules in lung cancer: disappearance of the D17 epitope of CD55 in small-cell carcinoma.
Sakuma T; Kodama K; Hara T; Eshita Y; Shibata N; Matsumoto M; Seya T; Mori Y
Jpn J Cancer Res; 1993 Jul; 84(7):753-9. PubMed ID: 7690355
[TBL] [Abstract][Full Text] [Related]
19. Protection of thyroid cancer cells by complement-regulatory factors.
Yamakawa M; Yamada K; Tsuge T; Ohrui H; Ogata T; Dobashi M; Imai Y
Cancer; 1994 Jun; 73(11):2808-17. PubMed ID: 7514955
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).
Watson R; Wearmouth E; McLoughlin AC; Jackson A; Ward S; Bertram P; Bennaceur K; Barker CE; Pappworth IY; Kavanagh D; Lea SM; Atkinson JP; Goodship TH; Marchbank KJ
Mol Immunol; 2015 Feb; 63(2):287-96. PubMed ID: 25150608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
